Product Details for NDA 019681
AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
3.5%;25GM/100ML
Marketing Status: Discontinued
3.5%;5GM/100ML
Marketing Status: Discontinued
4.25%;10GM/100ML
Marketing Status: Discontinued
4.25%;20GM/100ML
Marketing Status: Discontinued
4.25%;25GM/100ML
Marketing Status: Discontinued
5%;25GM/100ML
Marketing Status: Discontinued
3.5%;25GM/100ML
Marketing Status: Discontinued
Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.5%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 001
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
Proprietary Name: AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.5%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 001
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
3.5%;5GM/100ML
Marketing Status: Discontinued
Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.5%;5GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 002
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
Proprietary Name: AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.5%;5GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 002
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
4.25%;10GM/100ML
Marketing Status: Discontinued
Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;10GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 004
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
Proprietary Name: AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;10GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 004
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
4.25%;20GM/100ML
Marketing Status: Discontinued
Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;20GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 005
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
Proprietary Name: AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;20GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 005
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
4.25%;25GM/100ML
Marketing Status: Discontinued
Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 003
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
Proprietary Name: AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 003
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
5%;25GM/100ML
Marketing Status: Discontinued
Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 006
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019681
Product Number: 006
Approval Date: Nov 1, 1988
Applicant Holder Full Name: HOSPIRA WORLDWIDE, INC
Marketing Status: Discontinued
Patent and Exclusivity Information